Do It Yourself Stock Investor

Interview: Veru Healthcare CEO Dr. Mitchell Steiner

by DIYSI
January 09, 2017

During the early-80s Dr. Mitchell S. Steiner realized there was more to being a urologist. He chose a route in molecular biology, something of an emerging field back then. His studies began in the pre-Viagra era; most approaches were invasive and castration was common for prostate cancer.

Somewhere in the first fifteen minutes of the interview I was reminded that urology and the medical profession would lead to mentions most men steer away from: castration, STDs., sperm count, gonads, prophylactics... Yet, it was highly interesting like a visiting professor's colloquium. Read the full interview and listen to additional soundbites at Seeking Alpha.

*****

Disclosure: I am/we are long FHCO.